Research study Program year 2021 Source: CMS Open Payments

Phase-2 Study in Subjects with Ulcerative Colitis

Research payments

$113,298

27 payments

Through program year 2021, $113,298 in research payments was reported against Phase-2 Study in Subjects with Ulcerative Colitis, across 27 payments, paid by Amgen Inc..

Paid by: Amgen Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2021	Research	$113,298	27

Breakdown

Who paid Research payments · program year 2021

Amgen Inc. $113,298 27 payments

Who received the money Research payments · program year 2021

Insite Digestive Health Care - Camarillo Office Organisation paid for research $21,938 2 payments
Iact Health Organisation paid for research $18,516 2 payments
Interspond (Las Vegas Medical Research) Organisation paid for research $18,432 2 payments
West Central Gastroenterology Organisation paid for research $10,810 2 payments
Arizona Health Research Organisation paid for research $9,048 2 payments
Digestive Health Specialists Of The Southeast Organisation paid for research $3,083 1 payment
Options Health Research, LLC Organisation paid for research $3,083 1 payment
Grand Teton Research Group Organisation paid for research $2,974 1 payment
Wisconsin Center For Advanced Research Organisation paid for research $2,921 1 payment
Ohio Gastroenterology And Liver Institute Organisation paid for research $2,908 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.